Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Stomach Neoplasms 13Lung Neoplasms 9Adenocarcinoma 5Neoplasms 4Neoplasm Metastasis 4Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 3Squamous Cell Carcinoma of Head and Neck 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Urinary Bladder Neoplasms 1Thymoma 1Solid Tumors 1Solid Cancer 1Sarcoma 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neoplasms by Site 1Metastatic Small Intestinal Adenocarcinoma 1Metastatic Gastric Adenocarcinoma 1Melanoma 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Digestive System Neoplasms 1Desmoplastic Small Round Cell Tumor 1Clinical Stage IVB Gastric Cancer AJCC v8 1

Interventions

Fluorouracil 9Oxaliplatin 7Leucovorin 7Surveys and Questionnaires 6Blood Specimen Collection 6Bevacizumab 6Specimen Handling 5Gemcitabine 5Cetuximab 5Capecitabine 5fludarabine 4aldesleukin 4Standard of Care 4Irinotecan 4Cyclophosphamide 4Remote Patient Monitoring 3Radiosurgery 3Pafolacianine 3Nivolumab 3Endoscopic Mucosal Resection 3Cisplatin 3130-nm albumin-bound paclitaxel 3encorafenib 2Tomography, X-Ray Computed 2Sunitinib 2Referral and Consultation 2Radiotherapy 2Practice Guidelines as Topic 2Pemetrexed 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Ramucirumab × 1 year × Clear all
NCT05980416 2025-11-14

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Elevation Oncology

Phase 1 Terminated
88 enrolled 18 charts
Gastrointestinal

Adenocarcinoma, Digestive System Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡